List of partners

AMU (AFMB-UVE) France.

Architecture and Function of Biological Macromolecules& Unit Of Emerging Viruses


Institute of Biochemistry, University of Lübeck

Structural Basis of Viral Infections


University of Leuven (K.U.Leuven)

Institute for Medical Research, Department of Microbiology and Immunology


LUMC, the Netherlands

Department of Medical Microbiology, Leiden University Medical Center


EMC, the Netherlands

Department of Virology, Erasmus Medical Centre


Institut Pasteur, IP, Paris, France

UPRE Lyssavirus dynamics and host adaptation


Universitätsklinikum Heidelberg, UKL-HD, Germany

Department of Infectious Diseases


Radboud University Nijmegen Medical Centre (RUNMC), The Netherlands

Dept of Medical Microbiology


Riboxx GmbH, Riboxx, Germany

Developement of molecular tools for RNA-interference.


University of Oxford, Oxford, UK

Division of Structural Biology and OPPF-UK


CNRS, Montpellier, France (RI)

Institut des Biomolécules Max Mousseron,Centre National de Recherche Scientifique


CSIC, Spain

Consejo Superior de Investigaciones Científicas


GPhL,United Kingdom

Global Phasing Ltd


Pike Pharma GmbH, Pike, Switzerland


UIBK, Austria

University of Innsbruck


University of Hamburg, UHH, Germany

Institute of Organic Chemistry, Faculty of Mathematics, Informatics and Natural Sciences


Shanghai Institute of Materia Medica (SIMM), China

Drug Discovery and Design Center,


KRICT, Republic of Korea

Korea Research Institute of Chemical Technology


National Central University, Taoyuan, Taiwan

Department of Chemistry, College of Science


Univesita degli studi di Milano, Italy

Structural Biology Laboratory


Leipzig Universitatet, Germany

Medicinal Chemistry


CISTIM, Belgium

Centrum voor Innovatie en Stimulatie van Medicijnontwikkeling.


 

Associated Partners

IVSAS, Slovakia

Institute of Virology, Slovak Academy of Science, Bratislava, Slovakia

BNI,Hamburg, Germany

Bernhard-Nocht- Institute for Tropical Medicine

Institut Pasteur (IP), Lyon

Unité de Biologie des Infections Virales Emergentes (UBIVE)

The research leading to these results has received funding from the European Union Seventh Programme (FP7 2007/2013) under grant agreement n°250644-SILVER